Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variants
Yushiro Endo, Tomohiro Koga, Masataka Umeda, Kaori Furukawa, Motoi Takenaka, Atsushi Kawakami
Topics & Concepts
CanakinumabMEFVMedicineExonColchicineDiseaseInternal medicineGeneticsMutationBiologyGeneAnakinraGene mutationViral-associated cancers and disordersHistiocytic Disorders and TreatmentsInflammasome and immune disorders